Evidence map›Paper›PMID 11070031›Full record

ArticleJournal of virology2000

Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells.

G W Kemble, P Annunziato, O Lungu, R E Winter, T A Cha, S J Silverstein, R R Spaete

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. The Structures and Functions of VZV Glycoproteins.Current topics in microbiology and immunology · 2023
    Article
  5. Varicella-Zoster Virus-Genetics, Molecular Evolution and Recombination.Current topics in microbiology and immunology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Varicella-zoster.Handbook of clinical neurology · 2014
    Review
  13. Article
  14. Article
  15. Article
  16. Review: The neurobiology of varicella zoster virus infection.Neuropathology and applied neurobiology · 2011
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

G W KembleAviron, Mountain View, California 94043, USA.
P Annunziato
O Lungu
R E Winter
T A Cha
S J Silverstein
R R Spaete
Columbia University · USPediatrics and Genetics · US

Funding

Thioredoxin mediated Acinetobacter baumannii colonization in the GI tractR21AI124021 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI ARULANANDAM, BERNARD PRAGASH · 2016 to 2017
$404k
VARICELLA ZOSTER VIRUS REACTIVATION AND ITS PREVENTIONK08AI001409 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ANNUNZIATO, PAULA W · 1996 to 2000
$123k
NIAID NIH HHS AI-01409NIAID NIH HHS AI-124021NIAID NIH HHS R21 AI124021
6 · The paper itself

Abstract

We report the discovery of a novel gene in the varicella-zoster virus (VZV) genome, designated open reading frame (ORF) S/L. This gene, located at the left end of the prototype VZV genome isomer, expresses a polyadenylated mRNA containing a splice within the 3' untranslated region in virus-infected cells. Sequence analysis reveals significant differences between the ORF S/Ls of wild-type and attenuated strains of VZV. Antisera raised to a bacterially expressed portion of ORF S/L reacted specifically with a 21-kDa protein synthesized in cells infected with a VZV clinical isolate and with the original vaccine strain of VZV (Oka-ATCC). Cells infected with other VZV strains, including a wild-type strain that has been extensively passaged in tissue culture and commercially produced vaccine strains of Oka, synthesize a family of proteins ranging in size from 21 to 30 kDa that react with the anti-ORF S/L antiserum. MeWO cells infected with recombinant VZV harboring mutations in the C-terminal region of the ORF S/L gene lost adherence to the stratum and adjacent cells, resulting in an altered plaque morphology. Immunohistochemical analysis of VZV-infected cells demonstrated that ORF S/L protein localizes to the cytoplasm. ORF S/L protein was present in skin lesions of individuals with primary or reactivated infection and in the neurons of a dorsal root ganglion during virus reactivation.

Indexed as

Genome, ViralOpen Reading FramesAdultAmino Acid SequenceAnimalsBase SequenceChlorocebus aethiopsCytoplasmGanglia, SpinalHerpesvirus 3, HumanHumansMolecular Sequence DataMutationRabbitsRecombination, GeneticRNA, ViralRNA, ViralViral Proteins

Identifiers

PMID11070031
PMCPMC113236
OpenAlexW2153534226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.